# Laminar Pharmaceuticals

Source: https://onco.cc/companies/laminar-pharmaceuticals/  
OnCo record `laminar-pharmaceuticals` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Laminar Pharmaceuticals is a Spain-based biotechnology company running 2 late-stage cancer trials of LAM561 in glioma & glioblastoma.

## Summary

Laminar Pharmaceuticals, based in Palma de Mallorca, Spain, is a biotechnology company. Laminar Pharma is a biopharmaceutical company developing 'melitherapy', a therapeutic approach targeting membrane lipids rather than proteins or DNA, for conditions including cancer and Alzheimer's disease. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing LAM561 in glioma & glioblastoma. The largest, NCT04250922 (LAM561 With RT and TMZ for Adults With Glioblastoma), plans to enrol 144 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor
- HQ: Palma de Mallorca
- Type: biotech
- Website: https://www.laminarpharma.com

## Sources

- Official website: https://www.laminarpharma.com
- ClinicalTrials.gov: trials led by Laminar Pharmaceuticals: https://clinicaltrials.gov/search?lead=Laminar%20Pharmaceuticals

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- drugs: [LAM561](https://onco.cc/drugs/lam561/)
- trials: [LAM561 With RT and TMZ for Adults With Glioblastoma](https://onco.cc/trials/nct04250922/), [Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors](https://onco.cc/trials/nct04299191/)

---
JSON: https://onco.cc/api/v1/entities/laminar-pharmaceuticals.json